 |
Technical Data |
|
T9162-73D |
Tumor Necrosis Factor Receptor 2, Recombinant, Human, Western Blot Control (Tumor Necrosis Factor Receptor Superfamily Member 1B, Tumor Necrosis Factor Receptor 2, TNF-R2, Tumor Necrosis Factor Receptor Type II, TNF-RII, TNFR-II, p75, p80 TNF-alpha Recept |
10ug |
| Growth Factors, Cytokines | Storage: -20°CShipping: Blue Ice |
|
TNF beta is a potent multifunctional cytokine produced mainly by activated T and B lymphocytes. The protein has been shown to have a specific potent cytotoxic activity on tumor cells and a variety of other target cells as well as being a mediator of inflammation and immune function. Source: Recombinant corresponding to aa35-205 from human TNF beta, fused to 6x His-tag at N-terminal, expressed in E. coli. Applications: Suitable for use in Western Blot as a control. Other applications not tested. Recommended Dilution: Optimal dilutions to be determined by the researcher. Storage and Stability: May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer. |
Source: E. coli Purity: Purified (SDS-PAGE). Concentration: As reported Form: Supplied as a liquid in 25mM Tris-HCl, pH6.8, 50mM DTT, 1% SDS, 0.1% Bromophenol Blue, 2.5% glycerol. Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological. |
|
1. Ruddle, N.H. (1992) Curr. Opin. Immunol. 4(3): 327-332. 2. Port.er, A.G. (1990) FEMS Microbiol. Immunol. 2(4): 193- 199
|
||